Vijaya Diagnostic’s shares rose over 1 percent in early trading on September 25 following the announcement of a new MD & CEO. As of 9:24 a.m., the stock of Vijaya Diagnostic was trading 1.04 percent higher at Rs 460.35 on the NSE.
During the annual general meeting, the shareholders of the diagnostic chain Vijaya Diagnostic approved the appointment of Sura Suprita Reddy, who is part of the promoter and promoter group, as the Managing Director and Chief Executive Officer of the company for a consecutive five-year term starting from July 1, 2023. Sura has been a member of the company since 2003 and has been responsible for overseeing the company’s overall strategy, clinical excellence, operations, and expansion since that time.
Have you read?
Twenty-First-Century Communication Etiquette.
Igniting Wellness in the Workplace.
How CIOs Can Harness the Power of Automation While Prioritizing Human Connection.
Packaging Your Way to Success: How Effective Packaging Boosts Business.
The Military Mindset for Entrepreneurial Success.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Thank you for supporting our journalism. Subscribe here.
For media queries, please contact: email@example.com